FIBROBODIES Trademark

Trademark Overview


On Monday, August 24, 2020, a trademark application was filed for FIBROBODIES with the United States Patent and Trademark Office. The USPTO has given the FIBROBODIES trademark a serial number of 90133236. The federal status of this trademark filing is REGISTERED as of Tuesday, March 22, 2022. This trademark is owned by LinXis B.V.. The FIBROBODIES trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical ...

Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease

Medical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products

Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
fibrobodies

General Information


Serial Number90133236
Word MarkFIBROBODIES
Filing DateMonday, August 24, 2020
Status700 - REGISTERED
Status DateTuesday, March 22, 2022
Registration Number6674974
Registration DateTuesday, March 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for medical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; carrier excipients consisting of compounds that facilitate delivery of pharmaceutical preparations
Pseudo MarkFIBRO BODIES
Goods and ServicesChemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease
Goods and ServicesMedical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products
Goods and ServicesPharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, September 26, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 26, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 26, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 26, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLinXis B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAMSTERDAM 1081GM
NL

Party NameLinXis B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAMSTERDAM 1081GM
NL

Party NameLinXis B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAMSTERDAM 1081GM
NL

Trademark Events


Event DateEvent Description
Tuesday, March 22, 2022REGISTERED-PRINCIPAL REGISTER
Friday, February 11, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 18, 2022NOTICE OF ALLOWANCE CANCELLED
Friday, February 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 18, 2022TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 2, 2021ASSIGNED TO LIE
Thursday, March 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 27, 2020NON-FINAL ACTION E-MAILED
Sunday, December 27, 2020NON-FINAL ACTION WRITTEN
Saturday, December 19, 2020ASSIGNED TO EXAMINER
Saturday, September 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 27, 2020NEW APPLICATION ENTERED IN TRAM